Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1981 Oct;12(4):465–474. doi: 10.1111/j.1365-2125.1981.tb01252.x

Assessment of natriuretic drugs.

C J Roberts, T K Daneshmend
PMCID: PMC1401899  PMID: 7295482

Full text

PDF
465

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison M. E., Lindsay M. K., Kennedy A. C. Oral bumetanide in chronic renal failure. Postgrad Med J. 1975;51 (Suppl 6):47–50. [PubMed] [Google Scholar]
  2. Amery A., Berthaux P., Bulpitt C., Deruyttere M., de Schaepdryver A., Dollery C., Fagard R., Forette F., Hellemans J., Lund-Johansen P. Glucose intolerance during diuretic therapy. Results of trial by the European Working Party on Hypertension in the Elderly. Lancet. 1978 Apr 1;1(8066):681–683. doi: 10.1016/s0140-6736(78)90797-3. [DOI] [PubMed] [Google Scholar]
  3. Barclay J. E., Lee H. A. Clinical and pharmacokinetic studies on bumetanide in chronic renal failure. Postgrad Med J. 1975;51 (Suppl 6):43–46. [PubMed] [Google Scholar]
  4. Beermann B., Groschinsky-Grind M. Clinical pharmacokinetics of diuretics. Clin Pharmacokinet. 1980 May-Jun;5(3):221–245. doi: 10.2165/00003088-198005030-00003. [DOI] [PubMed] [Google Scholar]
  5. Beermann B., Groschinsky-Grind M. Pharmacokinetics of hydrochlorothiazide in patients with congestive heart failure. Br J Clin Pharmacol. 1979 Jun;7(6):579–583. doi: 10.1111/j.1365-2125.1979.tb04646.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bourke E., Asbury M. J., O'Sullivan S., Gatenby P. B. The sites of action of bumetanide in man. Eur J Pharmacol. 1973 Sep;23(3):283–289. doi: 10.1016/0014-2999(73)90096-4. [DOI] [PubMed] [Google Scholar]
  7. Bourke E. Some aspects of the renal action and clinical pharmacology of oral bumetanide in man. Postgrad Med J. 1975;51 (Suppl 6):23–26. [PubMed] [Google Scholar]
  8. Branch R. A., Roberts C. J., Homeida M., Levine D. Determinants of response to frusemide in normal subjects. Br J Clin Pharmacol. 1977 Apr;4(2):121–127. doi: 10.1111/j.1365-2125.1977.tb00682.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Daneshmend T. K., Homeida M., Roberts C. J., Dombey S. The effects of a combination of piretanide and triamterene in healthy subjects. Br J Clin Pharmacol. 1981 Jan;11(1):106–108. doi: 10.1111/j.1365-2125.1981.tb01117.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dargie H. J., Allison M. E., Kennedy A. C., Gray M. J. High dosage metolazone in chronic renal failure. Br Med J. 1972 Oct 28;4(5834):196–198. doi: 10.1136/bmj.4.5834.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Davies D. L., Wilson G. M. Diuretics: mechanism of action and clinical application. Drugs. 1975;9(3):178–226. doi: 10.2165/00003495-197509030-00003. [DOI] [PubMed] [Google Scholar]
  12. Gröbner W., Zöllner N. Uricosuric therapy and urate solubility in blood and urine. Postgrad Med J. 1979;55 (Suppl 3):26–31. [PubMed] [Google Scholar]
  13. Hadj Aissa A., Pozet N., Labeeuw M., Pellet M., Traeger J. Acute effect of high dose (48 mg) of piretanide in advanced renal insufficiency. Br J Clin Pharmacol. 1981 Jan;11(1):63–68. doi: 10.1111/j.1365-2125.1981.tb01103.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Homeida M., Roberts C. J., Dombey S. L. A single dose comparison of piretanide and bumetanide in congestive cardiac failure. Br J Clin Pharmacol. 1979 Aug;8(2):173–178. doi: 10.1111/j.1365-2125.1979.tb05817.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kampmann J. P., Hansen J. M. Glomerular filtration rate and creatinine clearance. Br J Clin Pharmacol. 1981 Jul;12(1):7–14. doi: 10.1111/j.1365-2125.1981.tb01848.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kohner E. M., Dollery C. T., Lowy C., Schumer B. Effect of diuretic therapy on glucose tolerance in hypertensive patients. Lancet. 1971 May 15;1(7707):986–990. doi: 10.1016/s0140-6736(71)91385-7. [DOI] [PubMed] [Google Scholar]
  17. Lee M. R. Effects of drugs on sodium metabolism. Br J Clin Pharmacol. 1981 Aug;12(2):103–109. doi: 10.1111/j.1365-2125.1981.tb01187.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lee M. R. Effects of drugs on water metabolism. Br J Clin Pharmacol. 1981 Sep;12(3):289–293. doi: 10.1111/j.1365-2125.1981.tb01216.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lewis P. J., Kohner E. M., Petrie A., Dollery C. T. Deterioration of glucose tolerance in hypertensive patients on prolonged diuretic treatment. Lancet. 1976 Mar 13;1(7959):564–566. doi: 10.1016/s0140-6736(76)90359-7. [DOI] [PubMed] [Google Scholar]
  20. Marshall A. J., Barritt D. W., Pocock J., Heaton S. T. Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension. Lancet. 1977 Feb 5;1(8006):271–274. doi: 10.1016/s0140-6736(77)91822-0. [DOI] [PubMed] [Google Scholar]
  21. Muth R. G. Diuretic properties of furosemide in renal disease. Ann Intern Med. 1968 Aug;69(2):249–261. doi: 10.7326/0003-4819-69-2-249. [DOI] [PubMed] [Google Scholar]
  22. Nicholls M. G., Espiner E. A., Donald R. A., Hughes H. Aldosterone and its regulation during diuresis in patients with gross congestive heart failure. Clin Sci Mol Med. 1974 Oct;47(4):301–315. doi: 10.1042/cs0470301. [DOI] [PubMed] [Google Scholar]
  23. Olsen K. H., Sigurd B., Hesse B., Steiness E., Leth A. Diuretic action of bumetanide in congestive heart failure. Postgrad Med J. 1975;51 (Suppl 6):54–63. [PubMed] [Google Scholar]
  24. Roberts C. J., Daneshmend T., Hopton M. Uric acid excretion related to pharmacokinetics of frusemide [proceedings]. Br J Clin Pharmacol. 1979 Oct;8(4):394P–394P. doi: 10.1111/j.1365-2125.1979.tb04741.x. [DOI] [PubMed] [Google Scholar]
  25. Roberts C. J., Homeida M., Roberts F., Bogie W. Effects of piretanide, bumetanide and frusemide on electrolyte and urate excretion in normal subjects. Br J Clin Pharmacol. 1978 Aug;6(2):129–133. doi: 10.1111/j.1365-2125.1978.tb00837.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Roberts C. J., Marshall A. J., Heaton S., Barritt D. W. Comparison of natriuretic, uricosuric, and antihypertensive properties of tienilic acid, bendrofluazide, and spironolactone. Br Med J. 1979 Jan 27;1(6158):224–226. doi: 10.1136/bmj.1.6158.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Roberts C. J., Mitchell J. V., Donley A. J. Hyponatraemia: adverse effect of diuretic treatment. Br Med J. 1977 Jan 22;1(6055):210–210. doi: 10.1136/bmj.1.6055.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. SUKI W., RECTOR F. C., Jr, SELDIN D. W. THE SITE OF ACTION OF FUROSEMIDE AND OTHER SULFONAMIDE DIURETICS IN THE DOG. J Clin Invest. 1965 Sep;44:1458–1469. doi: 10.1172/JCI105252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Stote R. M., Dubb J. W., Familiar R., Erb B., Weiherer S., Alexander F. Ticrynafen: site of natriuretic activity. Nephron. 1979;23 (Suppl 1):25–32. doi: 10.1159/000181664. [DOI] [PubMed] [Google Scholar]
  30. Teredesai P., Puschett J. B. Acute effects of piretanide in normal subjects. Clin Pharmacol Ther. 1979 Mar;25(3):331–339. doi: 10.1002/cpt1979253331. [DOI] [PubMed] [Google Scholar]
  31. Tweeddale M. G., Ogilvie R. I., Ruedy J. Antihypertensive and biochemical effects of chlorthalidone. Clin Pharmacol Ther. 1977 Nov;22(5 Pt 1):519–527. doi: 10.1002/cpt1977225part1519. [DOI] [PubMed] [Google Scholar]
  32. de Wardener H. E. Control of sodium reabsorption. Br Med J. 1969 Sep 20;3(5672):676–683. doi: 10.1136/bmj.3.5672.676. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES